This project is oriented towards determining factors that regulate the fate of transmembrane proteins on the cell surface the secretory pathway and at other organelles including mitochondria. One aspect of this project relates to determining the role of the ubiquitin system in mitochondrial membrane dynamics and how this in turn relates to cellular energetics in cancer. This project was begun in yeast and is now being expanded to mammalian systems. In preliminary studies we have determined that multiple ubiquitin ligases play roles in determining the fate of a critical protein involved in mitochondrial fusion, which is an essential step in preserving oxidative phosphorylation and mitochondrial DNA inheritance. The exact mechanisms whereby these two ligase function is under investigation in the laboratory. A major aspect of this project relates to degradation from the endoplasmic reticulum. Together with collaborators we are stdying E2s and E3s critical to this process. This work has implications for Parkinson's disease where the ubiquitin ligase Parkin is believed to play a critical role in degrading a misfolded protein from the ER. We now have preliminary evidence that other E3s plays roles in this process as well. gp78, also known as the tumor autocrine motility factor receptor (AMFR), was discovered by our laboratory to be a ubiquitin ligase resident to the endoplasmic reticulum. We have recently determined that gp78 plays essential roles in the degradation of multiple substrates functioning together with an E2 known as MmUBC7 (Ube2g2). We have now determined that multiple domains within gp78 function together to mediate its ubiquitin ligase activity. These include its RING finger, a ubiquitin-binding Cue domain and a novel region that specifically recruits Ube2g2 independent of the RING finger, referred to as the G2BR. Moreover, we now know that expressing the G2BR in in isolation can block ERAD and induce ER stress and are exploring the potential for such expression or other means of blocking the interaction between the gp78 and Ube2g2 may represent a means to target cells that are predisposed to ER stress, such as multiple myeloma cells, to undergo apoptosis. This work is further being complemented by structural studies being carried out in collaboration with Dr. R. Andrew Byrd oriented towards understanding the solution structure of the G2BR bound to Ube2g2. gp78 levels are correlated with the metastatic potential of tumors including melanomas and lung cancers. We have now determined (in work not yet submitted for publication) that knocking down gp78 levels results in a decrease in migration of cells in response to AMF as well as to to other stimuli and an inhibition of migration in in vitro wound healing type experiments. In vivo studies in mice using knockdowns of gp78 and reexpression have now determined that gp78 does in fact play an important role in the metastatic potential of tumors and that this potential for metastasis requires intact ubiquitin ligase function of this protein. Further studies are underway to chacacterize the molecular basis for this activity as well as to identify substrates that might be playing critical roles in enhancing metastasis in response to gp78.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC009392-13
Application #
7337721
Study Section
(LPDS)
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
2006
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Martin, Damali N; Boersma, Brenda J; Yi, Ming et al. (2009) Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One 4:e4531
Das, Ranabir; Mariano, Jennifer; Tsai, Yien Che et al. (2009) Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol Cell 34:674-85
Kostova, Zlatka; Tsai, Yien Che; Weissman, Allan M (2007) Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation. Semin Cell Dev Biol 18:770-9
Brauweiler, A; Lorick, K L; Lee, J P et al. (2007) RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene. Oncogene 26:2263-71
Hakli, M; Lorick, K L; Weissman, A M et al. (2004) Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity. FEBS Lett 560:56-62
Fang, S; Weissman, A M (2004) A field guide to ubiquitylation. Cell Mol Life Sci 61:1546-61
Webster, Jack M; Tiwari, Swati; Weissman, Allan M et al. (2003) Inositol 1,4,5-trisphosphate receptor ubiquitination is mediated by mammalian Ubc7, a component of the endoplasmic reticulum-associated degradation pathway, and is inhibited by chelation of intracellular Zn2+. J Biol Chem 278:38238-46
Magnifico, Alessandra; Ettenberg, Seth; Yang, Cuihong et al. (2003) WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem 278:43169-77
Liang, Jun-Shan; Kim, Tonia; Fang, Shengyun et al. (2003) Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells. J Biol Chem 278:23984-8